Results of the Second Phase of the GER-e-TEC Experiment concerning the Telemonitoring of Elderly Patients Affected by COVID-19 Disease to Detect the Exacerbation of Geriatric Syndromes.
COVID-19
MyPredi platform
alerts
geriatric syndromes
telemonitoring
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
29 Oct 2021
29 Oct 2021
Historique:
received:
28
09
2021
accepted:
27
10
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
Coronavirus disease 2019 (COVID-19) has wreaked health and economic damage globally. This pandemic has created a difficult challenge for global public health. The coronavirus disease 2019 (COVID-19) pandemic has necessitated the use of new technologies and new processes to care for hospitalized patients, including elderly patients. Our team developed a telemonitoring program focused on the prevention of geriatric syndromes, the "GER-e-TEC COVID study". This second phase took place during the 3rd wave of the epidemic in France, between 14 December 2020 and 25 February 2021, conducted in the University Hospital of Strasbourg. 30 elderly patients affected by COVID-19 disease were monitored remotely; the mean age was 85.9 years and a male/female ratio of 1.5 to 1.11 (36.7%) died during the experiment. The patients used the telemedicine solution for an average of 27.3 days. 140,260 measurements were taken while monitoring the geriatric syndromes of the entire patient group. 4675 measurements were recorded per patient for geriatric disorders and risks. 319 measurements were recorded per patient per day. The telemedicine solution emitted a total of 1245 alerts while monitoring the geriatric syndromes of the entire patient group. In terms of sensitivity, the results were 100% for all geriatric risks and extremely satisfactory in terms of positive and negative predictive values. Survival analyses showed that gender played no role in the length of the hospital stay, regardless of the reason for the hospitalization (decompensated heart failure ( The MyPredi™ telemedicine system allows for the generation of automatic, non-intrusive alerts when the health of a COVID-19 elderly patient deteriorates due to risks associated with geriatric syndromes.
Sections du résumé
BACKGROUND
BACKGROUND
Coronavirus disease 2019 (COVID-19) has wreaked health and economic damage globally. This pandemic has created a difficult challenge for global public health. The coronavirus disease 2019 (COVID-19) pandemic has necessitated the use of new technologies and new processes to care for hospitalized patients, including elderly patients. Our team developed a telemonitoring program focused on the prevention of geriatric syndromes, the "GER-e-TEC COVID study".
METHODS
METHODS
This second phase took place during the 3rd wave of the epidemic in France, between 14 December 2020 and 25 February 2021, conducted in the University Hospital of Strasbourg.
RESULTS
RESULTS
30 elderly patients affected by COVID-19 disease were monitored remotely; the mean age was 85.9 years and a male/female ratio of 1.5 to 1.11 (36.7%) died during the experiment. The patients used the telemedicine solution for an average of 27.3 days. 140,260 measurements were taken while monitoring the geriatric syndromes of the entire patient group. 4675 measurements were recorded per patient for geriatric disorders and risks. 319 measurements were recorded per patient per day. The telemedicine solution emitted a total of 1245 alerts while monitoring the geriatric syndromes of the entire patient group. In terms of sensitivity, the results were 100% for all geriatric risks and extremely satisfactory in terms of positive and negative predictive values. Survival analyses showed that gender played no role in the length of the hospital stay, regardless of the reason for the hospitalization (decompensated heart failure (
CONCLUSIONS
CONCLUSIONS
The MyPredi™ telemedicine system allows for the generation of automatic, non-intrusive alerts when the health of a COVID-19 elderly patient deteriorates due to risks associated with geriatric syndromes.
Identifiants
pubmed: 34834469
pii: jpm11111117
doi: 10.3390/jpm11111117
pmc: PMC8621367
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
JMIR Public Health Surveill. 2020 Apr 15;6(2):e18811
pubmed: 32252023
Am J Med. 2014 Mar;127(3):183-7
pubmed: 24384059
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Am J Manag Care. 2020 Apr;26(4):147-148
pubmed: 32270980
CMAJ Open. 2020 May 23;8(2):E407-E413
pubmed: 32447283
J Med Internet Res. 2021 Feb 10;23(2):e25518
pubmed: 33529157
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
BMJ Case Rep. 2021 Feb 1;14(2):
pubmed: 33526540
Rev Clin Esp. 2020 Nov;220(8):472-479
pubmed: 33994572
Euro Surveill. 2020 Dec;25(48):
pubmed: 33272355
PLoS One. 2021 Mar 26;16(3):e0247635
pubmed: 33770093
J Med Internet Res. 2020 Sep 2;22(9):e20953
pubmed: 32833660
J Med Internet Res. 2021 Mar 9;23(3):e21064
pubmed: 33687341
BMJ Open. 2021 Mar 5;11(3):e044154
pubmed: 33674374
J Clin Med. 2020 Nov 26;9(12):
pubmed: 33256080
Medicines (Basel). 2020 Jul 23;7(8):
pubmed: 32717937